| Literature DB >> 35355278 |
Eliecer Coto1,2,3, Guillermo M Albaiceta2,3,4,5,6, Laura Amado-Rodríguez2,3,4,5,6, Marta García-Clemente2,7, Elías Cuesta-Llavona1,2, Daniel Vázquez-Coto1, Belén Alonso1, Sara Iglesias1, Santiago Melón2,8, Marta E Alvarez-Argüelles2,8, José A Boga2,8, Susana Rojo-Alba2,8, Sergio Pérez-Oliveira1,2, Victoria Alvarez1,2, Juan Gómez1,2.
Abstract
Furin is a protease that plays a key role in the infection cycle of SARS-CoV-2 by cleaving the viral proteins during the virus particle assembly. In addition, Furin regulates several physiological processes related to cardio-metabolic traits. DNA variants in the FURIN gene are candidates to regulate the risk of developing these traits as well as the susceptibility to severe COVID-19. We genotyped two functional FURIN variants (rs6224/rs4702) in 428 COVID-19 patients in the intensive care unit. The association with death (N = 106) and hypertension, diabetes, and hyperlipidaemia was statistically evaluated. The risk of death was associated with age, hypertension, and hypercholesterolemia. The two FURIN alleles linked to higher expression (rs6224 T and rs4702 A) were significantly increased in the death cases (odds ratio= 1.40 and 1.43). Homozygosis for the two high expression genotypes (rs6224 TT and rs4702 AA) and for the T-A haplotype was associated with an increased risk of hypercholesterolemia. In the multiple logistic regression both, hypercholesterolemia and the TT + AA genotype were significantly associated with death. In conclusion, besides its association with hypercholesterolemia, FURIN variants might be independent risk factors for the risk of death among COVID-19 patients.Entities:
Keywords: COVID-19; FURIN; SARS-CoV-2; gene polymorphism; hypercholesterolemia
Mesh:
Substances:
Year: 2022 PMID: 35355278 PMCID: PMC9088626 DOI: 10.1002/jmv.27748
Source DB: PubMed Journal: J Med Virol ISSN: 0146-6615 Impact factor: 20.693